+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Urinary Tract Infection Testing Market by Indication (Cystitis, Pyelonephritis, Urethritis), Test Kits (Home Test Kits, Laboratory Test Kits), Tests, End User - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666357
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Urinary Tract Infection Testing Market size was estimated at USD 1.40 billion in 2023, USD 1.47 billion in 2024, and is expected to grow at a CAGR of 4.75% to reach USD 1.94 billion by 2030.

Urinary tract infection (UTI) testing includes a range of diagnostic procedures used to ascertain the presence of infection in the urinary tract, an essential part of the system that creates, stores, and removes urine from the body. This infection is primarily caused by microbes, including bacteria, viruses, and fungi, though bacteria are the most common cause. Testing for UTIs is critical because these infections can lead to severe discomfort, and if left untreated, potentially serious health complications. The increase in the number of urinary tract infections globally is expanding the need for urinary tract infection (UTI) testing solutions.

Growing public awareness about the symptoms and risks associated with UTIs is creating a platform for urinary tract infection (UTI) testing solutions. The growing issue of antibiotic resistance and the high cost of UTI tests hampers the growth of the market. The rising development of rapid, reliable, and easy-to-use diagnostic tests that make UTI testing more accessible is expected to create opportunities for market growth.

Regional Insights

In the Americas, particularly in North America, there is a high prevalence of UTIs due to factors such as aging populations and a growing awareness of the importance of early detection and treatment. The United States holds a significant position in this market due to advanced healthcare infrastructure, high healthcare expenditure, and a strong presence of market players. The South American market is also growing steadily, driven by improving healthcare infrastructure and increasing access to diagnostic testing. The APAC region is witnessing rapid growth in the UTI testing market, attributed mainly to the increasing population, rising healthcare awareness, and advancements in healthcare facilities.

Economies such as China and India are at the forefront due to their large population bases and improving healthcare systems. The region also benefits from escalating investments in healthcare infrastructure and a growing middle class that can afford advanced healthcare services. Europe is a mature market for UTI testing, characterized by high healthcare standards, a well-established healthcare system, and widespread awareness about UTI prevention and treatment. The market is driven by technological advancements, an increase in healthcare spending, and supportive government initiatives. In contrast, the Middle East and Africa (MEA) present a mixed picture. The Gulf Cooperation Council (GCC) countries exhibit potential for growth due to increasing healthcare expenditure and initiatives to modernize healthcare facilities.

Market Trends by Segment

  • Tests: Rising usage of susceptibility testing to avoid prescribing antibiotics
  • End User: High potential for urinary tract infection testing in diagnostic laboratories to detect the presence of bacteria

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

PathogenDx's Eco-efficient D3 Array Platform Approach for Urinary Tract Infection Testing

PathogenDx addressed the demand for urinary tract infection (UTI) diagnostics by leveraging the D3 Array Platform, originally developed for COVID-19 tests. PathogenDx introduces a multiplex UTI test characterized by rapid results and reduced laboratory waste, thereby lowering operational costs and making testing more affordable for patients. This initiative is emblematic of a broader industry trend towards filling diagnostic gaps exposed by the pandemic, aiming to enhance testing accessibility and efficiency.

Vivoo Unveils Smart At-Home Testing Solution Advancing UTI Diagnostics

Vivoo has introduced a smart urinary tract infection (UTI) test, marking a significant advancement in at-home healthcare diagnostics. Leveraging state-of-the-art deep learning image processing technology, this test allows users to obtain accurate results within seconds, streamlining the entire testing process to just two minutes. Designed for ease of use, customers simply apply urine to a strip and utilize a companion app to analyze the results, which are then made available almost instantaneously. This method simplifies the diagnostic process and facilitates seamless communication between consumers and healthcare providers by digitalizing and sharing test data directly through the app.

A Novel Diagnostic Sensor Developed by University of Texas at Dallas Researchers

Researchers at The University of Texas at Dallas have made significant strides in the timely diagnosis of urinary tract infections (UTIs) with the development of an innovative diagnostic sensor, potentially transforming patient care and antibiotic stewardship. This groundbreaking prototype offers an up to 85% accuracy rate in detecting UTIs within just five minutes by analyzing urine for three specific protein biomarkers. This swift and efficient diagnostic approach stands to revolutionize UTI management, addressing the pitfalls of current practices where antibiotics are often prescribed without definitive confirmation of a UTI, contributing to the problematic rise of antibiotic resistance among infectious bacteria.

Key Company Profiles

The report delves into recent significant developments in the Urinary Tract Infection Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., ACON Laboratories, Inc., Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health Inc., Chungdo Pharm Co., Ltd., F. Hoffmann-La Roche Ltd., Genetworx, LLC, Module Innovations Pvt. Ltd., Piramal Pharma Limited, QIAGEN GmbH, Randox Laboratories Ltd., Siemens Healthineers, Stryker Corporation, SYSMEX CORPORATION, T2 Biosystems, Inc., Thermo Fisher Scientific Inc., and Vivosens Inc.

This research report offers invaluable insights into various crucial aspects of the Urinary Tract Infection Testing Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of urinary tract infections worldwide
5.1.1.2. Complicated UTIs due to a rise in excessive use of antibiotics and drug resistance
5.1.2. Restraints
5.1.2.1. Product recall issues with the urinary tract infection testing solutions
5.1.3. Opportunities
5.1.3.1. Rising development of new imaging technologies and testing devices
5.1.3.2. Favorable initiatives by the government to increase rapid diagnostics
5.1.4. Challenges
5.1.4.1. Social stigma concerning urinary tract infections
5.2. Market Segmentation Analysis
5.2.1. Tests: Rising usage of susceptibility testing to avoid prescribing antibiotics
5.2.2. End User: High potential for urinary tract infection testing in diagnostic laboratories to detect the presence of bacteria
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Urinary Tract Infection Testing Market, by Indication
6.1. Introduction
6.2. Cystitis
6.3. Pyelonephritis
6.4. Urethritis
6.5. Vaginitis
7. Urinary Tract Infection Testing Market, by Test Kits
7.1. Introduction
7.2. Home Test Kits
7.3. Laboratory Test Kits
8. Urinary Tract Infection Testing Market, by Tests
8.1. Introduction
8.2. Susceptibility Testing
8.3. Urinalysis
8.4. Urine Cultures
9. Urinary Tract Infection Testing Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals
9.4. Nephropathy Clinics
10. Americas Urinary Tract Infection Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Urinary Tract Infection Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Urinary Tract Infection Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. PathogenDx's Eco-efficient D3 Array Platform Approach for Urinary Tract Infection Testing
13.3.2. Vivoo Unveils Smart At-Home Testing Solution Advancing UTI Diagnostics
13.3.3. A Novel Diagnostic Sensor Developed by University of Texas at Dallas Researchers
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. URINARY TRACT INFECTION TESTING MARKET RESEARCH PROCESS
FIGURE 2. URINARY TRACT INFECTION TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. URINARY TRACT INFECTION TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2030 (%)
FIGURE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. URINARY TRACT INFECTION TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. URINARY TRACT INFECTION TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. URINARY TRACT INFECTION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY CYSTITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URETHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY VAGINITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOME TEST KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST KITS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY LABORATORY TEST KITS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY SUSCEPTIBILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINALYSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY URINE CULTURES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEPHROPATHY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY NEPHROPATHY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 40. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 61. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 62. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 65. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 68. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 69. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 70. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 71. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 72. CANADA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 73. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 74. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 75. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 76. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 77. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 78. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 79. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 80. MEXICO URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 81. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 82. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 83. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 84. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 85. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 86. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES URINARY TRACT INFECTION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 92. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 94. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 96. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 101. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 102. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 103. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 104. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 105. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 106. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 112. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 113. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 114. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 115. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 116. CHINA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 117. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 118. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 119. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 120. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 121. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 122. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 123. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 124. INDIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 125. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 126. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 127. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 128. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 129. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 130. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 133. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 136. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 137. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 138. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 139. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 140. JAPAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 141. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 142. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 143. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 144. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 145. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 146. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 149. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 150. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 151. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 152. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 153. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 154. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 157. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 158. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 159. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 160. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 161. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 162. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 165. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 168. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 169. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 170. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 173. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 174. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 175. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 176. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 177. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 178. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 181. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 182. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 183. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 184. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 185. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 186. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 187. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 188. THAILAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 189. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 192. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 193. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 194. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 207. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 208. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 209. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 210. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 211. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 212. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 213. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 214. DENMARK URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 215. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 216. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 217. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 218. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 219. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 220. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 221. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 222. EGYPT URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 223. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 224. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 225. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 226. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 227. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 228. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 229. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 230. FINLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 231. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 232. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 233. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 234. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 235. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 236. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 237. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 238. FRANCE URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 239. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 240. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 241. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 242. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 243. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 244. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 245. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 246. GERMANY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 247. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 248. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 249. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 250. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 251. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 252. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 255. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 258. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 259. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 260. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 261. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 262. ITALY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 263. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 264. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 265. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 266. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 267. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 268. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 271. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 272. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 273. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 274. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 275. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 276. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 279. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 280. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 281. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 282. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 283. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 284. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 285. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 286. NORWAY URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 287. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 288. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 289. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 290. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 291. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 292. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 293. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 294. POLAND URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 295. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 296. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 297. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 298. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 299. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 300. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 301. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 302. QATAR URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 303. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 304. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 305. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 306. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 307. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 308. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 312. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2018-2023 (USD MILLION)
TABLE 314. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TEST KITS, 2024-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2018-2023 (USD MILLION)
TABLE 316. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY TESTS, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA URINARY TRACT INFECTION TESTING MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA URINARY TRACT INFECTION TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TA

Companies Mentioned

  • Abbott Laboratories
  • Accelerate Diagnostics, Inc.
  • ACON Laboratories, Inc.
  • Beckman Coulter, Inc. by Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cardinal Health Inc.
  • Chungdo Pharm Co., Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Genetworx, LLC
  • Module Innovations Pvt. Ltd.
  • Piramal Pharma Limited
  • QIAGEN GmbH
  • Randox Laboratories Ltd.
  • Siemens Healthineers
  • Stryker Corporation
  • SYSMEX CORPORATION
  • T2 Biosystems, Inc.
  • Thermo Fisher Scientific Inc.
  • Vivosens Inc.

Methodology

Loading
LOADING...

Table Information